Search

Home > New FDA Approvals > 077 - MIT study about drug approval rate; ZOMACTON® (somatropin) for growth hormone deficiency; VIVO surgical sealant
Podcast: New FDA Approvals
Episode:

077 - MIT study about drug approval rate; ZOMACTON® (somatropin) for growth hormone deficiency; VIVO surgical sealant
Category: Science & Medicine
Duration: 00:07:54
Publish Date: 2018-02-01 07:00:00
Description:

February 1, 2018

Please spread the word about this podcast! tell your friends and colleagues to go to “newfdaapprovals.com”

1:24 Probability of drug approval is about 14% for all therapies studied. http://www.hcanews.com/news/mit-researchers-use-big-data-to-track-drug-approval-likelihood

https://academic.oup.com/biostatistics/advance-article-abstract/doi/10.1093/biostatistics/kxx069/4817524?redirectedFrom=fulltext

4:03 Ferring's ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults https://www.prnewswire.com/news-releases/ferrings-zomacton-somatropin-for-injection-receives-fda-approval-to-treat-growth-hormone-deficiency-in-adults-300591478.html

5:10 Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO https://www.prnewswire.com/news-releases/grunenthal-group-receives-fdas-expedited-access-pathway-designation-for-vivo-672108443.html

Nascent Medical info@nascentmc.com
Total Play: 0